FUSCO, FERDINANDO
 Distribuzione geografica
Continente #
AS - Asia 4.647
EU - Europa 3.914
NA - Nord America 3.691
SA - Sud America 802
AF - Africa 151
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.218
Nazione #
US - Stati Uniti d'America 3.496
SG - Singapore 2.716
RU - Federazione Russa 1.938
IT - Italia 838
CN - Cina 834
BR - Brasile 680
HK - Hong Kong 451
VN - Vietnam 344
FI - Finlandia 201
DE - Germania 197
NL - Olanda 186
UA - Ucraina 135
CA - Canada 123
GB - Regno Unito 106
SE - Svezia 83
IE - Irlanda 75
AR - Argentina 57
CI - Costa d'Avorio 45
ZA - Sudafrica 44
IN - India 43
MX - Messico 43
BD - Bangladesh 38
TR - Turchia 32
ID - Indonesia 31
FR - Francia 30
EC - Ecuador 26
IQ - Iraq 24
JP - Giappone 24
PL - Polonia 23
ES - Italia 21
IR - Iran 13
MA - Marocco 12
PY - Paraguay 11
CH - Svizzera 10
TH - Thailandia 10
UZ - Uzbekistan 10
EG - Egitto 9
JO - Giordania 9
KE - Kenya 9
RS - Serbia 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
BE - Belgio 8
CO - Colombia 7
RO - Romania 7
CL - Cile 6
LT - Lituania 6
PE - Perù 6
SA - Arabia Saudita 6
AL - Albania 5
AZ - Azerbaigian 5
IL - Israele 5
KR - Corea 5
KZ - Kazakistan 5
LB - Libano 5
NI - Nicaragua 5
CZ - Repubblica Ceca 4
GA - Gabon 4
GT - Guatemala 4
HU - Ungheria 4
PH - Filippine 4
PK - Pakistan 4
SN - Senegal 4
UY - Uruguay 4
DK - Danimarca 3
DM - Dominica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GD - Grenada 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BJ - Benin 2
DJ - Gibuti 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NC - Nuova Caledonia 2
PA - Panama 2
PF - Polinesia Francese 2
PS - Palestinian Territory 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
CY - Cipro 1
DZ - Algeria 1
Totale 13.188
Città #
Singapore 1.088
Moscow 466
Hong Kong 448
Chandler 308
Ashburn 280
Beijing 270
Millbury 207
Princeton 177
Amsterdam 168
Santa Clara 142
Los Angeles 140
Nanjing 138
Naples 134
Boston 120
Ho Chi Minh City 118
Napoli 113
Munich 75
Buffalo 72
São Paulo 64
Wilmington 61
Hanoi 59
Ottawa 59
New York 52
Redondo Beach 52
Dallas 51
Jacksonville 51
Seattle 42
Nanchang 40
Des Moines 38
Hefei 38
Augusta 35
Shenyang 35
Norwalk 31
Milan 30
Hebei 29
The Dalles 29
Turku 28
Frankfurt am Main 26
Abidjan 25
Chicago 25
Denver 25
Boardman 24
Dong Ket 24
Rome 24
Stockholm 24
Falls Church 23
Ann Arbor 22
Montreal 22
Mexico City 21
Tianjin 21
Toronto 20
Warsaw 20
Brooklyn 19
Houston 19
Orem 18
Poplar 18
Tokyo 18
Atlanta 17
Jiaxing 17
Bologna 16
Manchester 15
Rio de Janeiro 15
Changsha 14
London 14
Ankara 13
Belo Horizonte 13
Haiphong 13
Johannesburg 13
Lawrence 13
Biên Hòa 12
Cambridge 12
Chennai 12
Redwood City 12
Curitiba 11
Da Nang 11
Goiânia 11
Phoenix 11
San Jose 11
Baghdad 10
Jakarta 10
San Francisco 10
Zola Predosa 10
Amman 9
Brasília 9
Guayaquil 9
Nairobi 9
Salt Lake City 9
Benevento 8
Kunming 8
Ninh Bình 8
Nuremberg 8
Porto Alegre 8
Ribeirão Preto 8
Shanghai 8
Washington 8
Bangkok 7
Dhaka 7
Dublin 7
Eindhoven 7
Fortaleza 7
Totale 6.186
Nome #
Colonvaginoplastica versus ileovaginoplastica nel transessualismo andro-ginoide: studio di confronto.” 207
CISTECTOMIA RADICALE CON NEOVESCICA ORTOTOPICA IN PAZIENTI CON LAVARIANTE NESTED DEL CARCINOMA UROTELIALE: NOSTRA ESPERIENZA CLINICACON FOLLOW-UP DI 36 MESI. 181
Perceptions, Expectations, Preferences, and Attitudes Toward Premature Ejaculation, Its Diagnosis and Topical Treatment with Fortacin™ Spray: Results from an Expert Panel Discussion 173
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals. 132
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors 128
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 126
Diagnostic accuracy of three tesla biparametric magnetic resonance imaging of the prostate, prostate specific antigen density and their combination for the detection of clinically significant prostate cancer: Results from a retrospective study 124
Vaginoplastica con flap penoscrotale nel transessualismo andro-ginoide 122
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 122
Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review 122
Does physical activity regulate prostate carcinogenesis and prostate cancer outcomes? A narrative review 121
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction 120
SPHINGOSINE-1PHOSPHATE INDUCES ENDOTHELIAL NOS ACTIVATION THROUGH PHOSPHORYLATION IN HUMAN CORPUS CAVERNOSUM 120
Erectile dysfunction after surgical treatment. 116
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? 116
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy 116
Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study 115
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition. 114
Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? 112
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 109
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition 109
Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials 107
Could YouTubeTM encourage men on prostate checks? A contemporary analysis 105
Female sexual dysfunction: an update on physiopathology. 104
A case of highly aggressive anaplastic seminoma of the testis presenting as fungating scrotal lesion 103
Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results 103
Renal Transplantation Does Not Improve Erectile Function in Hemodialysed Patients. 102
Ejaculatory abstinence influences intravaginal ejaculatory latency time: Results from a prospective randomized trial 102
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 100
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. 99
A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease 98
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study 96
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. 95
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections. 94
the detrusor muscle: an innocent victim of bladder outlet obstruction 94
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 94
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. 93
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections 93
UROTENSIN II AS A POSSIBLE SERUM MARKER OF ERECTILE DYSFUNCTION 92
VAGINOPLASTICA CON FLAP PENOSCROTALE NEL TRANSESSUALISMO ANDRO-GINOIDE 91
An ex vivo standardized assay to measure human platelet cGMP 91
Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? 90
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA EDOPO IL TRAPIANTO RENALE 89
Incidentally discovered pelvic paraganglioma: A case report 88
Endogenous urotensin–II induced-penile erection trhough eNOS phosphorylation in human corpus cavernosum 87
"A new validated questionnaire in the clinical evaluation of female sexual dysfunction (FSDQ): an Italian proposal" 86
A rare case of male pelvic squamous cell carcinoma of unknown primary origin presenting as perineal abscess and urethral stenosis 86
QUALITà DELLA VITA SESSUALE E SODDISFAZIONE DEL PAZIENTE DOPO CHIRURGIA PENIS-SPARING PER LESIONI PENIENE BENIGNE, PREMALIGNE O MALIGNE 85
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 85
Erectile dysfunction after surgical treatment. 83
Erectile dysfunction after surgical treatment. 83
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trial 83
Invovement of beta-3-adrenergic receptor activation via Cyclic GMP-but not No-dependent mechanism in human corpus cavernosum function. 82
TADALAFIL ONCE DAILY AND EXTRACORPOREAL SHOCK WAVE THERAPY IN THE MANAGEMENT OF PATIENTS WITH PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION. RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL 82
Involvement of L-cysteine/H2S pathway in human bladder homeostasis 82
Endoscopic Spatulation of the Intramural Ureter: A Technique to Prevent Stenosis of the Ureterovesical Junction in Patients Undergoing Resection of the Ureteral Orifice 82
Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: Still many gaps 82
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment 81
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 80
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica 80
Transperineal repair of a persistent rectourethral fistula using aporcine dermal graft 80
Endogenous urotensin II selectively modulates erectile function through eNOS 78
Trattamento del Late onset Hypogonadism con testosterone in Gel: dati clinici di efficacia e sicurezza 78
Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study 78
Female sexual dysfunction: an update on physiopathology. 77
Female sexual dysfunction: an update on physiopathology. 77
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: Results from a prospective randomized trial 77
Female sexual dysfunction: an update on physiopathology. ( Review ) 77
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies 77
A standardized procedure for using human corpus cavernosum stripa to evaluate drug activity and the role of mediators in Erectile Dysfunctions 75
The Role of the Hydrogen Sulfide Pathway in Male and Female Urogenital System in Health and Disease 75
Phase Ii Multicentric Study of Sunitinib In Metastatic Renal Cell Carcinoma (mrcc) With A Poor Prognosis Refractory To Immunotherapy 74
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. 73
ERYTHEMATOUS ERUPTION WITH LINEAR VESCICULATION AND EOSINOPHILIA AT BIRTH 73
BPH/LUTS and ED: Common Pharmacological Pathways for a Common Treatment 73
The detrusor muscle: an innocent victim of bladder outlet obstruction. 72
IL PROFILO SOCIO-CULTURALE E CLINICO DEI TRANSESSUALI ANDRO-GINOIDIIN ITALIA: REPORT SULLA NOSTRA ESPERIENZA DI 14 ANNI NEL TRATTAMENTODEI DISORDINI DI IDENTITÀ DI GENERE 72
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA E DOPO IL TRAPIANTO RENALE 72
Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium 72
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 71
STUDIO PROSPETTICO RANDOMIZZATO, DOPPIO CIECO, PLACEBO CONTROLLATO VOLTO A VALUTAREL’EFFICACIA DELL ESWT NEL TRATTAMENTO DELLA MALATTIA DI LA PEYRONIE 71
PROSTATECTOMIA RADICALE PERINEALE VS PROSTATECTOMIA RADICALERETROPUBICA IN PAZIENTI PRECEDENTEMENTE SOTTOPOSTI A CHIRURGIAPROSTATICA: RISULTATI CHIRURGICI E FUNZIONALI 71
Colonvaginoplastica versus ileovaginoplastica 71
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study. 70
The impact of non-urologic drugs on sexual function in men. 70
PROSTATECTOMIA RADICALE PERINEALE VS PROSTATECTOMIA RADICALE RETROPUBICA INPAZIENTI PRECEDENTEMENTE SOTTOPOSTI A CHIRURGIA PROSTATICA: RISULTATI CHIRURGICI EFUNZIONALI 69
L'IDROGENO SOLFORATO COME NUOVO MEDIATORE DELL'EREZIONE PENIENA NELL'UOMO 69
EFFICACY AND SAFETY OF CIPROFLOXACIN XR 1000 MG ONCE DAILY VERSUS CIPROFLOXACIN 500 MG TWICE DAILY IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS 69
Did men with erectile dysfunction discuss their condition with partner and physicians? A survey of men attending a free call information service. 68
Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. 68
CASO DI DUPLICAZIONE URETERALE INCOMPLETA CON MEGAURETERE ASSOCIATOA DISTRETTO SUPERIORE ESCLUSO E DISTRETTO INFERIORE PERFETTAMENTEFUNZIONANTE 67
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: Results with two different forms of therapy 67
Dapoxetine treatment in patients with lifelong premature ejaculation: The reasons of a "waterloo" 67
Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans 67
Female sexual dysfunction: an update on physiopathology 66
Nuova tecnica di biopsia di placca nella malattia di La Peyronie 66
Attività miorilassante periferica della apomorfina e di un agonista selettivo del recettore D1 sul tessuto cavernoso umano 66
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica 65
“Neurophysiological evaluation in primary premature ejaculation patients: our experience” 65
Medical expulsive therapy for distal ureteric stones: tamsulosin versus silodosin. 63
Totale 9.113
Categoria #
all - tutte 47.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 27 22 39 26 98 38
2021/2022960 20 7 15 10 6 19 12 34 87 152 131 467
2022/2023942 205 59 15 62 98 79 6 77 120 169 41 11
2023/2024693 26 77 157 33 44 42 16 51 7 20 153 67
2024/20254.305 283 320 14 84 33 99 394 232 551 457 1.451 387
2025/20264.695 967 528 761 704 1.316 409 10 0 0 0 0 0
Totale 13.493